110 related articles for article (PubMed ID: 23188445)
1. Invasive papillary carcinoma of the mammary gland: histopathologic and immunohistochemical aspects.
Eremia IA; Ciobanu M; Tenea T; Comănescu MV; Crăiţoiu S
Rom J Morphol Embryol; 2012; 53(3 Suppl):811-5. PubMed ID: 23188445
[TBL] [Abstract][Full Text] [Related]
2. Loss of myoepithelium is variable in solid papillary carcinoma of the breast.
Nicolas MM; Wu Y; Middleton LP; Gilcrease MZ
Histopathology; 2007 Nov; 51(5):657-65. PubMed ID: 17927587
[TBL] [Abstract][Full Text] [Related]
3. An unusual case of invasive papillary carcinoma of the breast.
Terzi A; Uner AH
Indian J Pathol Microbiol; 2012; 55(4):543-5. PubMed ID: 23455801
[TBL] [Abstract][Full Text] [Related]
4. Papillary transitional cell carcinoma of the breast: a report of five cases with distinction from eccrine acrospiroma.
Mooney EE; Tavassoli FA
Mod Pathol; 1999 Mar; 12(3):287-94. PubMed ID: 10102614
[TBL] [Abstract][Full Text] [Related]
5. Papillary lesions of the breast: selected diagnostic and management issues.
Collins LC; Schnitt SJ
Histopathology; 2008 Jan; 52(1):20-9. PubMed ID: 18171414
[TBL] [Abstract][Full Text] [Related]
6. Papillary neoplasia of the breast: immunohistochemically defined myoepithelial cells in the diagnosis of benign and malignant papillary breast neoplasms.
Raju UB; Lee MW; Zarbo RJ; Crissman JD
Mod Pathol; 1989 Nov; 2(6):569-76. PubMed ID: 2479944
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical staining of papillary breast lesions.
Troxell ML; Masek M; Sibley RK
Appl Immunohistochem Mol Morphol; 2007 Jun; 15(2):145-53. PubMed ID: 17525625
[TBL] [Abstract][Full Text] [Related]
8. Solid papillary ductal carcinoma in situ versus usual ductal hyperplasia in the breast: a potentially difficult distinction resolved by cytokeratin 5/6.
Rabban JT; Koerner FC; Lerwill MF
Hum Pathol; 2006 Jul; 37(7):787-93. PubMed ID: 16784976
[TBL] [Abstract][Full Text] [Related]
9. Double immunostaining with p63 and high-molecular-weight cytokeratins distinguishes borderline papillary lesions of the breast.
Ichihara S; Fujimoto T; Hashimoto K; Moritani S; Hasegawa M; Yokoi T
Pathol Int; 2007 Mar; 57(3):126-32. PubMed ID: 17295644
[TBL] [Abstract][Full Text] [Related]
10. New diagnostic approach to intracystic lesions of the breast by fiberoptic ductoscopy.
Yamamoto D; Ueda S; Senzaki H; Shoji T; Haijima H; Gondo H; Tanaka K
Anticancer Res; 2001; 21(6A):4113-6. PubMed ID: 11911303
[TBL] [Abstract][Full Text] [Related]
11. Practical Considerations in Breast Papillary Lesions: A Review of the Literature.
Agoumi M; Giambattista J; Hayes MM
Arch Pathol Lab Med; 2016 Aug; 140(8):770-90. PubMed ID: 27472236
[TBL] [Abstract][Full Text] [Related]
12. [Papillary cancer of the breast (clinico-morphological aspects)].
Ermilova VD; Krylova MO
Sov Med; 1990; (4):26-8. PubMed ID: 2374968
[TBL] [Abstract][Full Text] [Related]
13. The role of immunohistochemistry in the differential diagnosis of papillary lesions of the breast.
Tse GM; Tan PH; Moriya T
J Clin Pathol; 2009 May; 62(5):407-13. PubMed ID: 19126567
[TBL] [Abstract][Full Text] [Related]
14. Benign apocrine papillary lesions of the breast lacking or virtually lacking myoepithelial cells-potential pitfalls in diagnosing malignancy.
Cserni G
APMIS; 2012 Mar; 120(3):249-52. PubMed ID: 22339683
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemistry in the diagnosis of papillary lesions of the breast.
Tse GM; Ni YB; Tsang JY; Shao MM; Huang YH; Luo MH; Lacambra MD; Yamaguchi R; Tan PH
Histopathology; 2014 Dec; 65(6):839-53. PubMed ID: 24804569
[TBL] [Abstract][Full Text] [Related]
16. Utility of mammaglobin and gross cystic disease fluid protein-15 (GCDFP-15) in confirming a breast origin for recurrent tumors.
Chia SY; Thike AA; Cheok PY; Tan PH
Breast; 2010 Oct; 19(5):355-9. PubMed ID: 20347310
[TBL] [Abstract][Full Text] [Related]
17. Nipple aspirate fluid cytology in breast carcinoma.
Krishnamurthy S; Sneige N; Thompson PA; Marcy SM; Singletary SE; Cristofanilli M; Hunt KK; Kuerer HM
Cancer; 2003 Apr; 99(2):97-104. PubMed ID: 12704689
[TBL] [Abstract][Full Text] [Related]
18. [Papillary lesions of the breast: diagnostic imaging and contribution of percutaneous needle biopsy with 14G needle].
Bazzocchi M; Berra I; Francescutti GE; Del Frate C; Zuiani C; Puglisi F; Di Loreto C
Radiol Med; 2001 Jun; 101(6):424-31. PubMed ID: 11479438
[TBL] [Abstract][Full Text] [Related]
19. Solid variant of papillary carcinoma of nipple: an under recognized entity.
Sundaram S; Prathiba D; Rao S; Rajkumar A; Rajendiran S
Indian J Pathol Microbiol; 2010; 53(3):537-40. PubMed ID: 20699520
[TBL] [Abstract][Full Text] [Related]
20. Observer variability in the histopathological reporting of core biopsies of papillary breast lesions is reduced by the use of immunohistochemistry for CK5/6, calponin and p63.
Douglas-Jones A; Shah V; Morgan J; Dallimore N; Rashid M
Histopathology; 2005 Aug; 47(2):202-8. PubMed ID: 16045782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
